DALLAS, May 10, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Positron Corp. (OTCBB:POSC). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at: www.microstockprofit.com/ads/POSC
Positron Corp. (POSC) is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its product line to provide solutions to the Nuclear Medicine community ranging from imaging to radiopharmaceutical distribution. Positron products include the Attrius, a positron emission tomography (PET) imaging device; the Pulse, a single photon emission computerized tomography (SPECT) imaging device; the Nuclear Pharm-Assist, an automated radiopharmaceutical distribution device; and the Tech-Assist, a radiopharmaceutical injection shield. Positron's SPECT and PET cardiac molecular imaging devices are installed in more than 175 hospitals and physician offices worldwide. Positron offers a cardiac reasonably priced PET system in North America. Positron, through its China based joint venture, Neusoft Positron Medical Systems, has upgraded its PET imaging system.
Message Board Search for POSC: http://www.boardcentral.com/boards/POSC
In the report, the analyst notes:
"The Company generated revenues of $1,446,000 and $2,126,000 for the years ended December 31, 2009, and 2008, respectively. Revenue from service contracts totaled $827,000 and $1,150,000 for the years ended December 31, 2009, and 2008, respectively. The decrease in service is due to in large part to the continuous decline of sales of both PET systems and PulseCDC gamma cameras. Additionally, some existing service contracts were either terminated or moved to time and materials billing, which resulted in lower revenue.
"The Company's Nuclear Pharm-Assist®, an automated radiopharmaceutical dose dispensing device, aims to greatly transform the way healthcare providers serve patients seeking care for numerous cardiac and cancer diseases. The innovative device has been attracting significant new partners by streamlining the production, dispensing and delivery of radiopharmaceuticals."
To read the entire report visit: www.microstockprofit.com/ads/POSC
See what investors are saying about POSC at penny stock forum
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.